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ABSTRACT
“TEMPERATURE AND PH DEPENDENCE
OF THE CYCLIZATION OF CREATINE: A
STUDY VIA MASS SPECTROMETRY”
By Brian J. Diamond

The creatine to creatinine cyclization is of significant biological importance, providing
energy for muscle cells and indicating proper renal function. From a chemical
perspective, the rate at which creatine cyclizes to form creatinine has interested
researchers since the late 1920s, but the cyclization is poorly understood both
energetically and mechanistically. Mass spectroscopy was used to determine the rate of
creatine cyclization as a function of temperature and pH. Using these values, the
energetic parameters, activation energy and Arrhenius factor, were determined as a
function of pH to better understand this reaction and ultimately determine the mechanistic
process for this reaction. From our experiments, the activation energies and Arrhenius
factors for each experimental pH were found to be 83.1 kJ mol-1 and 9.6 at pH 1, 93.6 kJ
mol-1 and 11.8 at pH 3, and 79.1 kJ mol-1 and 9.0 at pH 5.
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CHAPTER 1 – BIOLOGY, COMMERICALIZAITON & RESEARCH

1.0.0 – Biology, Commercialization, & Research
The human body is a myriad of independent systems working symbiotically to sustain
life. Throughout this system, many mechanisms exist to provide and regenerate energy
that is required for the body to function properly.

The creatine-creatinine reaction has been intensely studied from both biological and
chemical perspectives1. In the body, the creatine-creatinine reaction is part of a system
that serves as an energy buffer and it plays a role as an indicator of renal function2.
Creatine cyclization has intrigued scientists since the early part of the 20th century
because of its simplistic appearance and biological importance.

1.1.0 - Biological Synthesis and Action
Creatine concentrations in the body stem from two sources: biological synthesis and diet.
The human body carries out this synthesis in different locations throughout the body.
Although two organs in the human body, the liver and pancreas, are able to directly
synthesize the compound, the organs where the majority of creatine synthesis takes place
is still under debate2. Since most literature cites the kidneys as the origin, this point of
view will be taken here.

The synthesis begins with the transfer of the amidino group of arginine to glycine. This
reaction, catalyzed by L-arginine:glycine amidinotransferase (AGAT), forms L-ornithine
and guanidinoacetic acid, as shown in Figure 1.1.0a.
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Figure 1.1.0a - Beginning of creatine biosynthesis.
Guanidinoacetate is synthesized in the kidneys and then transported to the liver where it
acquires a methyl group to become creatine.
After guanidinoacetate is synthesized in the kidneys, it is transported through the body to
the liver. There it acquires a methyl group from methionine via S-adenosyl-Lmethionine:N-guanidinoacetate methyl transferase (GAMT) to form creatine. The
creatine is then transported through the bloodstream and absorbed by tissues requiring
creatine. Desirable regulation of this process occurs in both locations. Creatine
synthesizing tissues like the liver have high concentrations of GAMT, but low
concentrations of AGAT3.

Once creatine is synthesized, it is then phosphorylated in the mitochondria to form
phosphorylcreatine (PCr). PCr is utilized in cells where creatine cannot be synthesized,
acting as a phosphate cache. In cells such as muscle, where energy demands greatly
fluctuate, PCr is readily available for hydrolysis to regenerate adenosinetriphosphate
(ATP) from adenosinediphosphate (ADP)2. This buffer allows the body to “catch up,”
generating ATP via glycolysis. If more creatine and PCr can be stored inside of these
types of cells, a larger reservoir of potential energy is available.
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A strenuous activity such as bench pressing can be used as an example. If I.B. Strong
were trying to squeeze out one last repetition for his set, he would be very close to using
all of the ATP available in his muscles. During that last rep, he would actually deplete
the ATP reserve in the muscles. After his energy source is gone, the body would then
undergo glycolysis to regenerate ATP, which is excruciating slow relative to energy
demand at that specific time. So while glycolysis is slowly beginning, the body will
hydrolyze the phosphate groups from the PCr that is stored in the muscle. This will
regenerate ATP and save the lift and pride of I.B. Strong.

Dietary creatine is absorbed through the digestive system and enters the bloodstream to
migrate to cells requiring creatine1. It is assumed that exogenous (dietary) creatine is
then treated identically to its biologically synthesized form. Dietary creatine is covered
more thoroughly in Section 1.2.0.
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Figure 1.1.0b – Creatine Metabolism
Schematic showing the synthesis/metabolism of creatine in the human body. Excerpted
from Wyss.

Creatine metabolism is illustrated in Figure 1.1.0b, shown above. An enzyme, creatine
kinase, is responsible for attaching and removing phosphate groups from the creatine
molecule. The enzyme maintains the Cr/PCr ATP/ADP equilibrium. As it is hydrolyzed,
PCr and biological creatine cyclize to form creatinine (Crn). Crn is a biologically
inactive molecule that the body excretes at a constant rate. On average, the pool of
biological creatine is converted to creatinine at a rate of approximately 2g per day2. If
dietary requirements to maintain a constant creatine concentration in the body are not
met, the body will then initiate creatine synthesis.
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1.2.0 - Dietary supplementation and Commercialization
The dietary supplement industry is a very wealthy industry. One only has to watch
television or read a magazine to be bombarded with advertisements of products claiming
to be the miracle drug for weight loss, muscle gain, fat burning, etc. The driving power
behind creatine is the Real™ scientific studies supporting claims of strength and muscle
gains. Every major dietary supplement manufacturer markets a creatine formulation
because it is one of the few products that actually work. This section will briefly
examine commercialized creatine and how it pertains to this study.

The concept behind dietary creatine supplementation is simple. Creatine is added to the
diet to increase the concentration of creatine and PCr available to regenerate ATP
(Section 1.1.0). By making a greater amount of energy available to muscles, the body
can be worked harder to increase mass, strength and endurance. Many studies show
significant increases in both muscle and serum creatine concentration during
supplementation, indicating the supplemented creatine is able to enter the bloodstream
and become incorporated into muscle cells, just as endogenous creatine1, 4.

A variety of athletes and biological conditions have been shown to benefit from creatine
supplementation. Sports requiring muscle endurance5 (such as cycling and running) as
well as sports requiring explosive movements (such as sprinting, weightlifting, football)
have demonstrated the added benefits of taking dietary creatine. Creatine has been
shown to provide a safe, legal approach to increasing athletic performance through
dietary supplementation6.
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In recent years, new creatine formulations have entered the consumer market. In addition
to supplements with various delivery mechanisms7, 8, liquid (aqueous solutions) creatine
supplements have become popular. The most recent of these studies suggest the creatine
in these liquid formulations has already cyclized to the inactive creatinine, implying a
lack of stability in aqueous solutions9. This is likely the reason that supplementation with
creatine serum (a liquid formulation) does not have as great of an effect as that of powder
supplements10.

1.3.0 - Medicinal Interest
Creatine has demonstrated additional uses other than a dietary supplementation to
enhance athletic performance. The compound has been shown to increase strength and
bone density in human subjects with Duchenne Muscular Dystrophy without additional
resistance training, meaning no additional exercise is required for the subjects. This
disease is a degenerative, muscle wasting disease that affects voluntary muscles primarily
in males11.

A research group at the University of Kentucky as demonstrated the use of creatine for
protection against brain trauma12. The group conducted experiments indicating creatine
supplementation reduced the amount of free fatty acids (FFAs) and lactic acid present
after a traumatic brain injury in rats. These acids are released after trauma, and cause
secondary injury to surrounding cells. Supplementing the diets of the rats with creatine
reduced the concentrations of the damaging acids, affording greater “neuroprotection”
than those rats without dietary creatine.
-6-

Dietary creatine supplementation has also been shown to reduce mental fatigue13 and
improve brain performance14. These are just several examples of many different types of
research being conducted with creatine. Future research will undoubtedly find additional
uses for this compound that are not associated with increased athletic performance.
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CHAPTER 2 – INTRODUCTION

2.0.0 – Introduction and Objectives
Since early in the 20th century, scientists have sought to thoroughly explain the
cyclization of creatine to creatinine. This reaction, occurring naturally in the human
body, provides cells with energy. Investigations to study the kinetics of the reaction have
been conducted using various wet chemical and spectroscopic techniques. As
instrumentation technology advanced, experiments utilizing these different techniques
were conducted. Beginning with classical wet chemistry techniques in the early part of
the 20th century and progressing through the use of high-pressure liquid chromatography,
several approaches have been employed to investigate this particular reaction. Thus far,
the studies have demonstrated the rate of the reaction has a clear temperature dependence
and a strong proton concentration dependence.

This study will follow the cyclization as a function of both temperature and pH using
mass spectroscopy. The novel approach of using mass spectrometry to determine the
cyclization rate will allow us to monitor both the reactants and products simultaneously.
Buffer systems will ensure constant proton concentration, enabling us to determine what
role protons may play in the cyclization process. By obtaining rate constants at each
temperature and pH, the activation energy and Arrhenius factor can be determined as a
function of pH. These parameters will further understanding of the kinetic process and,
ultimately, a possible mechanism for the reaction.
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2.1.0 - History
This section will outline the significant experiments performed attempting to understand
the cyclization, and the roll of pH and temperature. These experiments begin with early
colorimetric studies in the 1920s and progress to more modern techniques using highpressure liquid chromatography (HPLC) and mass spectrometry.

2.1.1 - Edgar and Wakefield
In 1923 Edgar and Wakefield conducted the first quantitative experiment to measure the
rate of cyclization of creatine to creatinine15. Until that time, all previous publications
were concerned with the conditions under which this reaction would go to completion or
if an equilibrium would be established. Acidic conditions were determined to be most
favorable. Edgar and Wakefield’s experiment attempted to quantify the apparent
catalytic properties of acid in the reaction. In their experiment, hydrochloric acid was
used as the catalytic proton source. Edgar and Wakefield hoped to demonstrate the rate
dependence as a function of temperature and pH.

Their experimental setup was rather simple and straightforward. Into a series of test
tubes, a known amount of creatine solution was added. Each tube contained a known
concentration of HCl. The test tubes, fitted with rubber stoppers, were held at constant
temperature through immersion in a series of boiling solvents. Four temperatures were
examined for the experiment: 100°, 78°, 56°, and 25° C. Boiling water, ethanol, and
acetone were utilized for the higher temperatures, and the temperature at 25°C was
maintained by a thermostat-controlled water bath.

-9-

Groups of identical tubes containing the reaction solution were then placed into the
temperature-controlled bath. At timed intervals, a single tube was removed, the reaction
was quenched, and the sample analyzed for the amount of creatinine it contained.
Removal of a single sample tube prevented bath temperature fluctuations that might
occur if removing aliquots from a common reaction vessel.

To quench the reaction in each tube, an equivalent amount of sodium hydroxide was used
to neutralize the hydrochloric acid solution. Previous experiments had shown the
reaction proceeded extremely slowly in neutral to alkaline pH. In addition to
neutralization, the sample was also rapidly cooled to aid in stopping the reaction. These
samples were then analyzed for creatinine content by employing the Folin method16.

The Folin method takes advantage of the fact that when creatinine is in solution with
picric acid and sodium hydroxide, a red color forms. The intensity of this color is
directly proportional to the concentration of creatinine in solution. By calorimetrically
comparing the sample solution to standard solutions treated in the same fashion, the
concentration of creatinine can be determined.

Colorimetric analysis was conducted in a Duboscq type of colorimeter, a schematic of
which is shown in Figure 2.1.1a. This instrument is somewhat similar in appearance to a
microscope. Two solutions, one reference and one sample, are placed in separate
compartments. Plungers, which determine the depth of solution light must pass through,
are inserted into both solutions. Light passing through each solution is then reflected to
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form one-half of a viewing field. The sample solution is mounted to a movable stage,
which is then manipulated until the light from the standard solution matches that of the
sample. Once the field is of uniform color, the concentration of the sample solution can
be determined from the following relationship:
c1l1 = c 2 l 2

Equation 2.1.1a

Figure 2.1.1a – Duboscq colorimeter
Cut-away view of Duboscq colorimeter. Light travels through each solution into each
prism, froming one-half of the viewing field. The sample stage is moved up or down
until the field is of uniform color.*
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where c is the concentration of the solutions and l is the path length of the prisms. When
the reference concentration is known, the sample concentration is given by the ratio of
path lengths multiplied by the reference concentration. The concentration of creatine at a
given time was calculated by subtracting the determined concentration of creatinine from
the initial creatine concentration. It was assumed that no side reactions took place during
the course of the experiment. The rate constant was calculated for each experiment by the
equation derived below.

Using the first order differential rate law,

d [ A]
= Rate = − k [ A]
dt

Equation 2.1.1b

where [A] is concentration and k is the rate constant. One can integrate to get

∫

A− x

A

t
d [ A]
= − k ∫ dt
0
[ A]

Equation 2.1.1c

After integrating and solving for k, the rate constant k is given by Equation 2.1.1d.

1
A
)
k = ln(
t
A− x

Equation 2.1.1d

where: A = initial Creatine concentration
x = Creatinine concentration

This equation looks at the ratio of the initial creatine concentration to the creatine
- 12 -

concentration at time t.

The results for their experiment are listed below in Table 2.1.1a. The table contains the
temperature, HCl concentration, initial creatine concentration, and rate constant for each
experiment.

Experiment
1
2
3
4
5
6
7
8

Temperature
25
57
78
100
78
100
78
78

[HCl], M
0.38
0.38
0.19
0.38
0.38
0.19
0.76
0.76

[Cr]0, M
0.0075
0.03
0.00447
0.0075
0.0075
0.00367
0.03
0.015

k, min-1
3.40E-05
7.77E-04
2.56E-03
2.82E-02
4.94E-03
1.37E-02
1.24E-02
1.26E-02

Table 2.1.1a – Table of experiments conducted by Edgar and Wakefield.
These experiments were conducted at various temperatures, Cr, and acid concentrations.
The rate, k, was determined by plotting the natural log of Cr concentration, from
Equation 2.1.1g, versus time.

Drawing meaningful conclusions about the rate being a function of both temperature and
pH from the published data is a bit of challenge. Unfortunately, very few of the
experiments have only one variable held constant. For example, the authors claim
experiments 3, 5, and 7 as evidence for the catalytic properties of protons in solution. As
the acid concentration in these experiments increases, the rate of the cyclization
apparently increases as well. It was reasonable for Edgar and Wakefield to conclude the
reaction was acid catalyzed.

2.1.2 - Lillocci and Vernon

This section will outline the study conducted by Lillocci and Vernon in an attempt to
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determine the mechanism by which creatine cyclizes. In the experiments, the cyclization
rates of three different compounds were measured.

Creatine cyclization was the focus of the Lillocci group in 198117. The researchers
measured cyclization rate with the primary objective of determining the mechanism by
which the cyclization proceeded. Using more contemporary instrumentation allowed the
group to examine the same reaction by directly measuring the amount of light absorbed
as the reaction proceeded. By using alternate methodologies to interrogate the same
process, new analytical techniques and previously published data can be verified or
shown to be inaccurate.

In 1981, Lillocci and Vernon sought to determine the mechanism by which
phosphocreatine cyclizes to form creatinine to better understand the reaction in vivo. As
seen in Section 1.1.0, phosphocreatine plays a vital role in ATP regeneration in muscle
cells. Three mechanisms were proposed for this cyclization. All three of the proposed
mechanisms depend on the order of the breaking of the P-N bond.
HO +
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In the first mechanism, Mechanism #1, the nitrogen bonds to carbon with the phosphate
attached forming phosphorocreatinine. The phosphate group is then hydrolyzed to form
creatinine. The second mechanism, Mechanism #2, shows the phosphate group
hydrolyzed first, forming creatine. Creatine then cyclizes to form creatinine. In the third
mechanism, Mechanism #3, the phosphate hydrolysis of the phosphate group is
concerted with the carbon-nitrogen bond formation and dehydration.

Lillocci and Vernon measured the rates of three reactions: hydrolysis of
phosphorocreatine, hydrolysis of phosphorocreatinine, and cyclization of creatine to
creatinine. All of the experiments were carried out at 30° C in 2N HCl. Since this group
was not concerned with the roll of acid catalysis, they used conditions that forced the
reaction to completion. Low pH solutions provided a relatively fast reaction rate.
According to the research group, creatinine is the predominate product in the hydrolysis
of phosphorocreatine under these conditions. The rates were determined by measuring
the change in absorbance at 230nm.

To determine the rate constant by this method, Beer’s Law is used. According to Beer’s
Law, the concentration of a solution is directly proportional to the measured absorbance

- 15 -

at a particular wavelength.

A = εlc

Equation 2.1.2a

Here, A is the measured absorbance, ε is the extinction coefficient for a particular
compound at a given wavelength, and c is the concentration of the compound in solution.
In the above equation, ε and l are constants, with A α c. Looking at the integrated rate
law for a first order reaction, concentration can be expressed as a function of absorbance.

The same derivation for determining creatine concentration used by Edgar and Wakefield
can be applied in Lillocci and Vernon’s experiments, with a few substitutions.
Rearranging Equation 2.1.1d, we have,

ln [A]t = ln [A]0-kt

Equation 2.1.2b

ln (At-Ac) = ln (A0-Ac)-kt

Equation 2.1.2c

with [A] substituted with initial and time dependent concentrations, [A]0, and [A]t. In
Equation 2.1.2c, concentration [A] has been replaced with absorbance, A. The
absorbances have been corrected by subtracting the absorbance of the solution after the
reaction has went to completion, Ac. This correction accounts for any reactant not
forming product. A plot of the creatine concentration vs time using Equation 2.1.2c,
should yield a linear graph with the slope equal to the rate constant of the reaction.
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The following rates were obtained for the reactions: 2.34x10-2 min-1 for the hydrolysis of
phosphorocreatine to creatinine and Pi; 4.63x10-3 min-1 for the hydrolysis of
phosphorocreatinine to creatinine and Pi; 4.76x10-4 min-1 for the cyclization of creatine to
creatinine. These results provide an indication as to which of the proposed mechanisms
would possibly be correct.

Based on their data, Lillocci and Vernon concluded phosphorocreatinine has a very low
probability of being an intermediate of this reaction, excluding Mechanism #1 from the
list of possible reaction routes. The rate of this hydrolysis is five times slower than that
of phosphorocreatine, indicating the ring would not close before the phosphate group is
removed. The large difference in the cyclization rates between phosphocreatine and
creatine would seem to prohibit the initial formation of creatine by hydrolysis of the
phosphate group followed by cyclization. This excludes Mechanism #2 as a plausible
explanation for a mechanism. According to their experiment, Mechanism #3 would be
the most probable path of cyclization of the three proposed mechanisms.

In Lillocci’s experiment, more advanced optical instrumentation was utilized to study the
cyclization. By using an instrument to measure light absorption rather than the human
eye, human error should be minimized with respect to the measurement. However, when
the creatine cyclization experiment was repeated for the present study, the results were
inconclusive. Unfortunately, Lillocci did not publish the UV spectra that were used to
determine the rates for the reactions. There was also a lack of indication of time between
data points.
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2.1.3 - Witkowska

This section will outline the experiment performed by Witkowska, which attempted to
determine the influence of acid concentration on the rate of cyclization. Her results show
the cyclization rate has pH dependence.

In 1985, Witkowska investigated the cyclization rate of creatine as a function of pH at a
fixed temperature18. Her experiment was one of the first studies to employ buffer
solutions for maintaining a constant pH throughout the duration of the reaction. Since the
reaction rate had previously been demonstrated to be pH sensitive, the use of buffer
systems should prevent any cyclization rate fluctuations due to pH changes.

For her experiment, 5 or 10mM creatine solutions were prepared. These solutions were
then adjusted to the desired pH value with sodium phthalate, glycine and phosphate
buffers that included sodium hydroxide, hydrochloric acid, and sodium chloride. The
samples solutions had pH values ranging from 1.2 to 7.0. The solutions were then placed
in a water bath at 60 or 100°C. At timed intervals, samples were taken from the solutions
and analyzed for creatinine concentration.

The creatinine concentration was determined by the alkaline picrate method, much like
that of Edgar and Wakefield (Section 2.1.1). Analysis of pH was also conducted on these
samples to ensure the stability of the buffer system. The actual creatinine concentration
is given by the following equation,
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x = A0 − ( A0 − x 0)e − kt

Where:

Equation 2.1.3a

x

= actual concentration of creatinine

x0

= initial concentration of creatinine

A0

= initial concentration of creatine

k

= rate constant

t

= time of reaction

Rearranging the equation gives:

( A0 − x0 )e − kt = A0 − x

Equation 2.1.3b

After taking the natural log of the equation, it is the same as Equation 2.1.1d substituted
with the creatinine concentration, x0.

ln( A0 − x0 ) − kt = ln( A0 − x)

Equation 2.1.3c

Plotting the natural log of the concentration of creatine versus time using Equation
2.1.3c, the slope of the line will be equal to the rate constant, k.

The following results, Table 2.1.3a, are an excerpt from the body of data given in her
publication. This table contains the pH at which the experiment was conducted, the
initial creatine concentration, type of buffer used, and the rate of the reaction. The plot in
Figure 2.1.3a is all of Witkowska’s data. All of these results were obtained at 60°C.
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pH
1.2
3
3
3.4
5
7

[Cr]0, mM
5
5
10
10
5
5

k, min-1
1.80E-04
8.83E-04
8.45E-04
1.14E-03
2.15E-04
7.72E-05

Buffer
Glycine
Phthalate
Glycine
Phthalate
Phthalate
Phosphate

Table 2.1.3a – Selected experiments from Witkowska’s publication.
Her experiments were conducted at various pH values in different buffer systems.

0.08
0.07

k per hour

0.06
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0.04
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0.02
0.01
0
0
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Figure 2.1.3a - Plot of Witkowska’s data of the rate constant vs pH.
The pH dependence is clear from the plot.

Rather than the rate being directly proportional to the acid concentration, her results show
an increase in the cyclization rate until approximately pH 3.4. At pH 3.4, the rate starts
to decline as pH increases. This data suggests the term “acid catalyzed” may not be
entirely correct. Witkowska acknowledges the pH dependence, but attempts no
explanation as to what would cause it. This type of pH dependence has been seen in the
literature as early as the 1950s and 1960s. Typically, it is attributed to a change from one
rate-limiting step at low pH to a different rate-limiting step at a higher pH.
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2.1.4 – Jencks

Jencks, in the late 1950s and early 1960s19, 20, studied the idea of a pH dependent rate. In
his experiments, he studied reaction rates several amines and carbonyls as a function of
pH. Using UV/VIS spectroscopy, he determined the rate of the reactions by measuring
the change in absorbance as a function of time. Jencks concluded the pH dependence
was due to a shift from one rate limiting step to a second rate limiting step because of the
change in pH.

His experiments measured oxime and semicarbazone formation during the reaction of
hydroxylamine with both acetone and furfural. The reaction profile, shown in Figure
2.1.4a, clearly shows the pH dependence of the reaction.
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H2O

Figure 2.1.4a – Jencks reaction profile.
General pH dependent two step reaction. Reaction rate constants of hydroxylamine and
acetone as a function of pH.

Shown above are the results from the reaction of hydroxylamine and acetone. Jencks
concludes the first step in the reaction, nucleophillic attack on the carbonyl, is fast at
higher pH due to a high concentration of the base. The second step, dehydration, is the
slow step because of a lack of protons required to protonate the hydroxyl group. As the
pH decreases, the rate limiting steps are reversed. In more acidic conditions, there is less
of the reactive alkaline species present to attack the carbonyl. This first step is then the
rate limiting step. Since there are an abundance of protons in solution, the dehydration
step then becomes the fast step.

This theory is based on a change in population, with a static activation energy for each

- 22 -

step. As pH changes, the populations of reactive species also change. The changes in
populations are what affect the rate of the reaction.

2.1.5 – Wang & Yin

Wang and Yin conducted an experiment determining the concentrations of the different
microspecies, of creatine in solution as a function of pH21. They found a protonated
species, neutral species, a zwitterion, and a negatively charged species. From pH 1 to
~11, three different structures were found in different concentrations depending on the
pH of the solution. The negative species is not formed until pH 12, and is not pictured.
Their determined structures are illustrated in Figure 2.1.5a.
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O
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Figure 2.1.5a - Microspecies of creatine molecule
Determined microspecies of creatine in solution by Wang and Yin.

Based on their data, the Wang and Yin constructed a plot of the relative concentrations of
the microspecies as a function of pH. This plot has been recreated using their values and
is shown in Figure 2.1.5b.
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Figure 2.1.5b – Recreated Wang & Yin plot.
Illustrative plot of relative concentration of microspecies of creatine as a function of pH
based on equilibrium data from Wang and Yin collected at 20°C.

From Figure 2.1.5b, we can see the protonated form of creatine is the dominant species
at low pH. As the solution pH increases, the zwitterion becomes the most dominant
species. The neutral species is present in extremely low concentrations at any pH. If we
expand the lower region of the graph, we see figure 2.1.5c.
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Figure 2.1.5c – Recreated Wang & Yin plot expanded.
Expanded plot based on equilibrium data of Wang and Yin collected at 20°C and an
estimation of ∆Grxn = 16.6 kJ. Proton concentration as a function of pH has been added
to show where acid concentration would become a limiting factor.

From this plot, we can see the neutral creatine concentration peaks at ~ pH 3. As the pH
continues to increase, the neutral species remains at a constant concentration. At pH 5,
the acid concentration is significantly reduced and virtually non-existent when compared
to pH 1 or 3.
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2.2.0 – Modern Instrumentation

This section will examine how more modern instrumentation has been used to both
quantify creatine and creatinine reaction rates. Included in this section is a description of
the instrumentation used for analysis in this study.

2.2.1 – Mass Spectrometry

In this section, mass spectrometry is examined as a technique to both detect and quantify
creatine and creatinine in various matrices. A description of past and present mass
spectrometry techniques will be described.

Several methods have been discussed regarding the quantification of both creatine and
creatinine in solution. In 1997, Yasuda et al. published an experiment outlining a method
for determining concentrations of creatine, creatinine, and guanidinoacetic acid
simultaneously in both urine and serum21. This method was a combination of liquid
chromatography (LC) and mass spectrometry. The research group first cleaned the
samples by column assay to remove any interfering components. Using the separated
fractions from the column assay, samples were analyzed using LC-atmospheric pressure
chemical ionization mass spectrometry (LC-APCI MS).

The method applied for sample analysis is a combination of two instruments. The LC will
separate the sample constituents based on column affinity. As the samples are eluted
from the LC column, the eluent is analyzed by the mass spectrometer. When the sample
enters the mass spectrometer, it must first be ionized. This particular group chose APCI

- 26 -

as an ionization source for their experiment.

Using this method, the researchers were able to achieve linear results for large
concentration ranges for the calibration curves of each compound. For creatine the range
was 20-500µg/ml, for creatinine the range was 200-300µg/ml, and for guanidinoacetic
acid the range was 20-500µg/ml. Based on the close correlation with the analyses by
conventional color methods, this particular procedure is an accurate and reliable method
to determine the concentrations of the three compounds simultaneously.

Bodamer et al. developed a procedure to specifically screen for guanidinoacetate
methyltransferase (GAMT) deficiency22. This is a rare disorder that affects muscular and
sometimes psychological development. Dietary creatine supplementation has been
shown to be effective in treating the disease characterized by low plasma creatine
concentrations with unusually elevated levels of guanidinoacetate. Rather than using
APCI as an ionization source, this group chose electrospray ionization to ionize the
compounds of interest. Bodamer et al found a linear range of 1-20µmol/L for
guanidinoacetate and 10-125µmol/L for creatine in the calibration curves.

Although neither of these studies was concerned with rate determination, both are closely
related to the experiments conducted for this study. Both publications utilize mass
spectrometry as an analytical tool for quantifying creatine in various media. From
Yasuda et al, detecting both creatine and creatinine in samples simultaneously with mass
spectrometry as an analytical instrument is central to this study21. Bodamer et al.
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demonstrated electrospray ionization as an effective ionization source for analyzing
creatine concentration in solution22. Both of theses studies provide accurate results when
analyzing both creatine and creatinine. These experiments help provide a foundation
upon which to build the experiments conducted for this study.

2.3.0 – Mass Spectrometry Background

Mass spectrometry has been an important analytical technique since the 1930s. For the
process to work, a charge must be placed on the molecule to be analyzed - a process
called ionization. The ions are accelerated by an electric field to a detection device that
measures the mass-to-charge (m/z) ratio23. The manner in which the charge is placed on
the molecule depends upon the ionization source used. Ionization techniques are
classified as hard or soft. Hard ionization changes the structure of the molecule, breaking
the molecule apart, while soft techniques leave the molecule intact. There are several
ionization sources available; however, only electrospray ionization will be discussed
here. The type of source used to achieve optimum analyte sensitivity would depend on
sample concentration and matrix. Since this study relied on electrospray ionization mass
spectrometry, this section will primarily be concerned with describing how this process
works.

2.3.1 – ESI-MS

Electrospray ionization (ESI) works by ionizing nonvolatile molecules from solution.
Analysis begins by injecting an analyte solution through a capillary tube using a syringe
pump. A large potential, usually ~4kV, is applied at the end of the tube. This potential is
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large enough to create a very fine mist of large, equally charged, droplets.

As the solvent evaporates away, the droplets shrink in size (Figure 2.3.2b). As the size
decreases, the charge concentration on the droplets surface increases. The evaporation
continues until the droplet reaches the Rayleigh Limit, the point at which the Coulombic
repulsions of positively charged species are greater than the surface tension of the
solvent. At that point, the drop “explodes” into smaller droplets. This process of
evaporation and explosion continues until a charged molecule is “naked,” and enters the
analyzer. This model of charge formation is called the charge residual model and is the
predominately accepted model of ion formation24. ESI-MS is well suited for polar
molecules that ionize easily in solution.

Figure 2.3.1b – ESI ionization
Graphical representation of droplet desolvation followed by repetitive coulombic
explosions until one ion remains per drop of solvent.
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For this study, ESI-MS was chosen for two primary reasons. First, the reason for this
study was to measure the cyclization of the creatine molecule as a function of acid
concentration and temperature. The high-energy chemical reactions taking place during
APCI may inhibit or accelerate the cyclization rate. Pragmatically, this was the sole
method of ionization suitable for this type of analysis available in this laboratory.
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CHAPTER 3 – EXPERIMENTAL METHOD

3.0.0– Experimental Method

This chapter will describe the instrument, chemical solutions, and the method used for
this study. Further, it will describe a series of protocols used to simultaneously analyze
relative concentrations of both creatine and creatinine in solution.

3.1.0 – LCQ Mass Spectrometer and Parameters

This section describes the instrumentation used for the experiments in this study. The
settings described here were empirically determined for the best results.

All analyses were performed on a Finnigan LCQ electrospray-ionization mass
spectrometer housed in the Chemistry Department at Marshall University and set in
positive ion mode. The spray voltage was 4.1kV, with the capillary voltage set at 25 V.
Sample flow rate was set at 3µL min-1. The sheath and auxiliary gas rates were set to 80
and 20 arbitrary units, respectively. At these instrument settings, the maximum amount
of signal was obtained for analysis.

3.2.0 - Buffer Solutions (Stock, Reaction, quench, spray)

Buffer solutions were a key component for this study. These solutions had to withstand
pH changes over the course of the reaction to prevent possible rate fluctuations.
Difficulty arose due to the fact that volatile buffers had to be used for the electrospray
process. We found that triflouric acetic acid, formic acid, acetic acid and ammonium
hydroxide buffer systems were suitable for this project.
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3.2.1 – Buffered Stock Creatine and Creatinine Solutions

Appropriate quantities of creatine (Aldrich) and creatinine (Aldrich), without further
purification, were combined with 10mM trifloroacetic acid (TFA) (Aldrich) to make
solutions of 10mM for each compound. These solutions were then titrated with
ammonium hydroxide to a pH of ~7.2-7.3 and placed in a refrigerator for storage.
Because the creatinine ring formation essentially stops at pH > 7.0, the combination of
low temperature and alkaline pH ensured the cyclization would not proceed. During
storage, buffered stock solution stability was tested using an equimolar buffered solution
of creatine/creatinine that was prepared and analyzed before each experiment (Section
3.3.0). The concentrations of each analyte in this buffered solution remained constant

throughout the course of the experiment.

3.2.2 – Reaction buffers

Following Witkowska’s results, reaction buffers were prepared with pHs of 1, 3, and 5.
These solutions were heavily buffered to hold the pH constant over the course of the
reaction. The pH 1 reaction buffer consists of 0.26 M TFA, with ammonium hydroxide
titrated in to achieve the desired pH value. The pH 3 reaction buffer was a 0.26M
formate buffer and was prepared in the same manner as above, only using formic acid. A
0.26M acetate buffer was prepared for the reaction at pH 5 by using combining acetic
acid and ammonium hydroxide. Because previous experiments saw no dependence on
buffer systems (Table 2.1.3a, pH 3 experiments), we do not anticipate that the type of
reaction buffer will have an influence on the cyclization rate.
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3.2.3 – Quench Buffers

To ensure the reaction would stop at the specified time, the reaction solution would need
to go from acidic (pH 1, 3, 5) to neutral/alkaline (pH >7.0) and from the reaction
temperature to quench temperature (0°C) in a short period of time. To accomplish this,
separate quenching buffers were prepared for each of the experimental pH solutions.
When combined with the reaction mixture, the quench buffers would bring the pH of the
reaction mixture up to pH 7.2-7.5 quickly relative to the time scale of the reaction.
These quench buffers, which were kept in an ice bath, contained different concentrations
of aqueous ammonium hydroxide that would neutralize the various reaction mixtures.
All quench buffers were combined in a 4:1 ratio with the reaction mixture to ensure a
constant analyte concentration for analysis.

3.2.4 – Spray Buffers

Electrospray ionization is extremely pH sensitive. To maximize signal during analysis,
the correct pH had to be determined. The optimum spray pH was empirically determined
to be ~2. A spray buffer was prepared to make the pH of all samples close to identical.
Since the quenched reactions had a barely alkaline pH, one spray buffer made from TFA
was prepared for all of the reaction solutions. For analysis, the sample solutions were
combined in a 2:1 ratio with the spray buffer.

3.3.0 - Ionization Efficiency

An experiment was conducted to determine the ionization efficiency of the two
compounds in the spray buffer solution. Ionization efficiency is a measure of how easily
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the compound of interest becomes ionized. Creatine and creatinine were combined in
1:10, 1:5, 1:1, 5:1, and 10:1 molar ratio solutions and analyzed in the mass spectrometer.
The intensities obtained from this experiment would indicate if an ionization factor would
be required for data analysis.

3.4.0 - Experimental Setup

The experimental setup, Figure 3.4.0a, was not unlike that of Edgar and Wakefield.
Water baths were maintained at temperatures ranging from 30-100°C in increments of ten
degrees. To ensure the accuracy of the water baths, the temperature was monitored with
the same thermometer throughout the process.

All reaction buffers were placed in separate screw-topped vials, topped with a Tefloncoated rubber septum. Experience proved normal screw-type caps failed to maintain
watertight seals after exposed to temperatures above 60°C. To ensure the reaction buffers
were thermally equilibrated with the water bath, the solutions in the vials were immersed
in the bath for approximately 30 minutes. After the temperature had stabilized, the
buffered stock creatine solutions were added to the equilibrated reaction buffers in a ratio
of 9:1 reaction buffer to creatine solution. The mixtures were then placed back into the
bath and remained until samples were taken. At timed intervals, a sample aliquot was
removed from the reaction mixture and quenched with its corresponding quench buffer.
The time required to take the samples was so as not to significantly affect the temperature
of the bath.

To ensure rapid quenching of the reaction, the quench buffers were kept in an ice bath.
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Based on the Arrhenius Equation, every 10°C decrease in temperature reduces the
reaction rate by a factor of two. Therefore, rapidly cooling the samples should halt the
reaction. Sample aliquots were extracted from the reaction vessels, and combined with
the quench buffers in a 4:1 ratio. After quenching each sample, it was placed in a deep
freezer, at -25°C, until analysis. The samples were thawed immediately before analysis
and mixed in a 2:1 ratio with the spray buffer.

Figure 3.4.0a – Pictorial representation of the experimental setup.
The buffered stock creatine solution is put into different reaction buffers and the reaction
proceeds at various temperatures. Sample aliquots are taken at intervals, quenched,
frozen, then analyzed.
3.5.0 - Sample analysis

After thawing and combining with the spray buffer, the samples were immediately
injected into the mass spectrometer. An average of 50 scans was taken for determining
the relative concentrations of both creatine and creatinine, based on the intensities
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obtained from the mass spectrum. To ensure consistent measurements, a 1:1 molar
standard solution of creatine:creatinine was analyzed each time samples were analyzed.
The relative intensities of this standard were consistent for each analysis.

3.6.0 – Data Analysis

This section outlines the methods and formulae used to analyze the rate data obtained
form the mass spectra. The formula used to determine creatine concentration for this
study is very similar to that of Edgar and Wakefield (Section 2.1.1.0), though it differs by
incorporating creatinine concentration into the calculation.

The concentration of creatine was determined as a ratio of the relative concentration of
creatine to the sum of both creatine and creatinine concentrations. The natural log of this
quantity was plotted versus time. The rate would be determined as the slope of the linear
data fit. The same derivation that was used for 2.1.1d will applies here.
⎛ [ A]t
ln⎜⎜
⎝ [ A]0

⎞
⎟⎟ = − kt
⎠

Equation 2.1.1d

In the experiment, the concentrations of both compounds were measured and factored
into the rate calculations. By using the creatinine concentration, the actual amount of
creatine that has cyclized was determined. If [A]0 is replaced with [Cr+Cn], and [A]t is
replaced with [Cr], the calculation becomes a function of both concentrations. At any
time, t, the concentration [Cr+Cn] will be equal to the initial concentration of creatine.
This normalization ensures that the difference in intensities from sample to sample will
not affect the final outcome of the data analysis. After this normalization, we have
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⎛ Cr ⎞
ln⎜
⎟ = − kt
⎝ Cr + Cn ⎠

Equation 3.6.0a

At t = 0, there is essentially zero creatinine in solution, and the ratio is one. As time
progresses, the amount of creatine decreases as the concentration of creatinine increases.
By plotting the natural log of the Cr/[Cr + Cn] ratio in Equation 3.6.0a as a function of
time, the rate constant, k, is determined by the slope of the line.
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CHAPTER 4 – RESULTS

4.0.0 – Results

This chapter will outline the results obtained from the experiments, described in Section
3.4.0, conducted for this study. The data from those experiments was processed, and the

relative concentrations of creatine and creatinine were calculated using Equation 3.6.0a.
Plots of these values versus time yielded the rate constant, k. Each point represents one
experiment conducted at each temperature and pH value. Cyclization rate constants for
all temperatures and pH values used for this study are summarized in Table 4.4.0a.

4.1.0 - Ionization Efficiency

The ionization efficiency experiment, Section 3.3.0, gave us an idea as to what relative
concentrations the intensities seen on the mass spectrum were measuring. From our
experiment, it was determined that the creatine ionized at 66% that of creatinine. This
means that the creatinine signal is ~1.33 times that of creatine, which was taken into
account during data analysis. This difference was consistent for each of the solutions
analyzed in the experiment.

4.2.0 – pH 1

The experiments conducted to obtain these results are outlined in Section 3.4.0. Each
experiment followed the described procedure without deviation. The following plot,
Figure 4.2.0a, was constructed using data from the experiments conducted at pH 1. The

natural log of the Cr/[Cr + Cn] ratio, using Equation 3.6.0a, was plotted versus time.
From these plots, the linear portion of the data was fit with a function to extract the rate
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ln (Cr/[Cr+Cn])

constant, k.

Figure 4.2.0a – pH 1 Cyclization kinetics
Plot of the natural log of creatine versus time from all experiments conducted at pH 1.
Creatine concentration was determined using Equation 3.6.0a. Cyclization rates for each
temperature are summarized in Table 4.4.0a.

4.3.0 – pH 3

The experiments conducted to obtain these results are outlined in Section 3.4.0,
following the described procedure without deviation. The following plot, Figure 4.3.0b,
was constructed using data from the experiments conducted at pH 3. Using Equation
3.6.0a, the natural log of the Cr/[Cr + Cn] ratio was determined and plotted versus time.
From these plots, the linear portion of the data was fit with a function to extract the rate
constant, k.
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ln (Cr/[Cr+Cn])

Figure 4.3.0a – pH 3 kinetics
Plot of the natural log of creatine versus time from all experiments conducted at pH 3.
Creatine concentration was determined using Equation 3.6.0a. Cyclization rates for each
temperature are summarized in Table 4.4.0a.

4.4.0 – pH 5

The experiments conducted to obtain these results are outlined in Section 3.4.0. Each
experiment followed the described procedure without deviation. The following plot,
Figure 4.4.0a, was constructed using data from the experiments conducted at pH 5. The

natural log of the Cr/[Cr + Cn] ratio, using Equation 3.6.0a, was plotted versus time.
From these plots, the linear portion of the data was fit with a function to extract the rate
constant, k.
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ln (Cr/[Cr+Cn])

Figure 4.4.0a – pH 5 kinetics
Plot of the natural log of creatine versus time from all experiments conducted at pH 5.
Creatine concentration was determined using Equation 3.6.0a. Cyclization rates for each
temperature are summarized in Table 4.4.0a.
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Experiment
1a
1b
1c
1d
1e
1f
1g
1h
3a
3b
3c
3d
3e
3f
3g
3h
5a
5b
5c
5d
5e
5f
5g
5h

Temperature °C
30
40
50
60
70
80
90
99
30
40
50
60
70
80
90
99
30
40
50
60
70
80
90
99

pH
1
1
1
1
1
1
1
1
3
3
3
3
3
3
3
3
5
5
5
5
5
5
5
5

k, min-1
2.08E-05
5.98E-05
1.52E-04
4.23E-04
8.54E-04
2.14E-03
4.66E-03
9.29E-03
4.75E-05
1.90E-04
5.41E-04
1.62E-03
4.85E-03
1.11E-02
2.04E-02
4.84E-02
2.42E-05
5.84E-05
1.64E-04
4.23E-04
9.57E-04
2.01E-03
3.80E-03
7.80E-03

Table 4.4.0a – Rate constant values from experiments
Rate constants obtained from experiments 1, 3, 5a-h. The rate constant, k, was
determined by the slope of the plots, Figures 4.2.0a, 4.3.0a, 4.4.0a, shown above.

4.5.0 – Activation Energies

Using the k values from Table 4.4.0a, an Arrhenius Plot, Figure 4.5.0a was constructed
for each experimental pH using the Arrhenius Equation.
ln k = ln A −

Ea
RT

Equation 4.5.1a

Plotting ln k versus 1/T yields a linear plot with the slope -Ea/RT. This plot shows the
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activation energy required for the cyclization of creatine to occur at pH 1, 3, and 5 from
30-99°C. The activation energies and the log of the pre-exponential values, log A, are
summarized in Table 4.5.0a.

Figure 4.5.0a – Arrhenius Plot from kinetic data
Arrhenius Plot of the natural log of k versus temperature. These plots indicate the amount
of energy required for the cyclization to occur at pH 1, 3, and 5.

The data from the Arrhenius plot is summarized in Table 4.5.0a. This table contains the
activation energies, Ea, for each pH value as well as the log of the Arrhenius factor, A.
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pH Ea kJ mol-1
log A
1
83.1 ± 0.77
9.6 ± 0.12
3
93.6 ± 1.60
11.8 ± 0.25
5
79.1 ± 0.82
9.0 ± 0.13
Table 4.5.0a – Activation energies and Arrhenius factors from experiments
Summarized values from Arrhenius Plot, Figure 4.4.0a. These values indicate the
amount of energy required for the cyclization (Ea) and the probability (logA) of it
occurring.
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CHAPTER 5 – DISCUSSION/CONCLUSION

5.0.0 – Discussion/Conclusion

We constructed our experiment following Edgar & Wakefield’s (Section 1.1.1) and
Witkowska’s (Section 1.1.3) experiments. From the pH dependence seen in
Witkowska’s experiment, we chose the key pH values of 1, 3, and 5 to more carefully
measure kinetic information, including Ea and A.

As expected, we observed rate dependence on reaction temperature. From the plots
shown in Chapter 4 (Sections 4.1.0-4.4.0), we saw the rate increase as the temperature
increased at all pH values. This had also been observed in previous experiments covered
in Chapter 1 (Sections 1.1.1-1.1.3).

From our data, presented in Sections 4.1.0-4.4.0, we determined the activation energy,
Ea, and the Arrhenius factor, A for the reaction at pH 1, 3, and 5. The activation energy
is the amount of energy required to proceed over the activation barrier of the reaction,
while the Arrhenius factor is a measurement of the population of molecules properly
oriented for the reaction to proceed. From the plot in Section 4.6.0, we obtained both of
these parameters for each pH at which the experiments were conducted.
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pH Ea kJ mol-1
log A
1
83.1 ± 0.77
9.6 ± 0.12
3
93.6 ± 1.60 11.8 ± 0.25
5
79.1 ± 0.82
9.0 ± 0.13
Table 4.5.0a – Activation energies and Arrhenius factors from experiments
Summarized values from Arrhenius Plot, Figure 4.4.0a. These values indicate the
amount of energy required for the cyclization (Ea) and the probability (logA) of it
occurring

The relationship between the activation energy and the Arrhenius factor can be seen in
the following cartoon representation of a reaction profile, Figure 5.0.0a. The profile in
blue would be similar to the cyclization of pH 1 or 5, the reactions with a comparatively
low Arrhenius factor.

Figure 5.0.0a – Illustrative Reaction profile
Illustrative profile of reactions with different Ea values

The reactant well for a low Arrhenius factor is shallow and broad, indicating a larger
variety of orientational states in which the molecule could exist. In black is a
representation of what the cyclization with a larger Arrhenius factor could resemble.
Here, the reactant well is narrower with steeper sides. The bottom of the well is lower
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than the blue profile, which would indicate a greater activation energy. The narrower
well indicates fewer orientational states in which the molecule could exist and more
orientational states that are favorable for the cyclization to proceed. Apparently at pH 3,
a larger population of creatine molecules have oriented favorably for cyclization to occur.

5.1.0 – What can we infer from our data?

According to Wang and yin, the pH of the solution determines the concentration of the
dominant creatine species. Lower pH solutions have a predominately protonated form of
creatine with very little of the reactive neutral species. Higher pH solutions have a higher
concentration of the zwitterion species, also with very little of the reactive neutral
species. At higher pH, according to Wang and Yin, the zwitterion is the primary
contributor to the neutral species concentration. Since this cyclization is on the order of
hours and days at any pH, it seems the reactive species would be the neutral molecule. If
the protonated or zwitterion species were the reactive species, it seems the cyclization
rate would dramatically increase at lower or higher pHs.

In order to obtain a theoretical model of the reaction, Dr. William Price of the Marshall
University Chemistry Department conducted molecular modeling experiments of this
cyclization using Gaussian26. The results for the computational experiments are seen in
Appendix A. The zwitterion cyclization has been modeled using the B3LYP/6-311+G**

level of computational theory. At this level of theory, the zwitterion species progresses
through the neutral species to an intermediate. We believe this intermediate acquires a
proton and undergoes dehydration to form creatinine. So far, the zwitterion is the only
species for which we have computational data.
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Based on the computational data, the transition state shown in Appendix A is obviously
not a transition state through which the reaction passes. If we look at the intermediate
shown in Appendix A, the energies approximately add up to the values we measured.
Additional computations are necessary for the protonated and neutral species.

Using the data we have from our experiments, we have constructed a possible mechanism
for this cyclization reaction. This mechanism is by no means definitive, but a guess as to
what is occurring during the cyclization process. Our proposed mechanism is shown in
Figure 5.1.0a.
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Figure 5.1.0a – Possible cyclization mechanism
Possible mechanism of creatine cyclization.
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H2O

In this mechanism, which is dependent on the neutral creatine species, the carbonyl
carbon undergoes nucleophillic attack from the nitrogen to form the first intermediate, I.
This intermediate acquires a proton to protonate the hydroxyl group forming I2. I2 then
dehydrates to form the last intermediate, I3 and water. The last step in the mechanism is
the loss of a proton which forms creatinine, Crn.

The proposed mechanism shown above progresses through three intermediates. Each of
these mechanistic steps would proceed at a given rate. These steps are shown in Figure
5.1.0b.

Step #1

k1

Cr0

Rate = k1[Cr0]

I
k-1
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Rate = k3[I2]
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I3

k4

Cn

+

H+

Rate = k4[I3]

k-4
Figure 5.1.0b – Proposed creatine cyclization mechanism
Proposed creatine cyclization mechanism broken down into individual components.

If we assume that the rate limiting step is Step #3 in the mechanism, the rapid
equilibrium approximation can be used for the other steps in this mechanism. This
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approximation assumes the other steps in the reaction reach equilibrium rapidly with
respect to the slow step in the process. If this assumption is correct, the rate will depend
on [I2]. Since [I2] cannot be directly measured, we can determine its value in terms of the
first intermediate, [I].

+

Equation 5.1.0a

I 2 = [ I ][kH−2 ]k2
If Equation 5.1.0a is re-inserted into the rate for Step #3,

Rate = k3 [ I ][ H + ]K EQ2

Equation 5.1.0b

Since [I] also cannot be directly measured, we again apply the rapid equilibrium
approximation to solve for [I] in terms of [Cr0]. Re-inserting these values into Equation
5.1.0b, gives the rate

Rate = k3 [Cr 0 ][ H + ]K EQ1 K EQ2

Equation 5.1.0c

From this rate law, the rate of cyclization clearly depends on the concentration of neutral
creatine species and proton concentration.

In constructing an argument that follows the Jencks model and computer simulations, one
could reasonably conclude that cyclization rate depends on two steps in the mechanism.
The first step in the cyclization mechanism, we believe, is the formation of an
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intermediate, I. From computational experiments conducted in the Price lab, we have a
theoretical intermediate structure, shown in Figure 5.1.0c.

Figure 5.1.0c – Theoretical intermediate structure
Calculated structure of theoretical cyclization intermediate

In the traditional Jencks model, k1 and k2 are considered constant and the rate limiting
step is determined by [Cr0] and [H+]. At low pH, the rate limiting step is the formation
of the intermediate species, Step #1 in the mechanism. The rate of this step is equal to
k1[Cr0], and would be slow due to the low concentration of the neutral creatine species.
Once the intermediate is formed, there is a high concentration of protons available for the
protonation step to occur easily.

If we go to higher pH, [Cr0] is more prevalent in solution, and the rate is given by
Equation 5.1.0c. From Figure 2.1.5c, we can get two important pieces of information.
First, the neutral species concentration peaks and remains constant at ~ pH 2.8; and at pH
5, the proton concentration has been significantly reduced. Based on Equation 5.1.0c, the
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rate of cyclization is dependent on [Cr0], which would be high, and [H+], which would be
much lower. So at higher pH, Step #3 would be the limiting factor due to a low acid
concentration.

This process would be pH dependent. At low pH, the formation of the intermediate
would be the slow step due to a low concentration of the zwitterion, which is the primary
source of the neutral reactive species. At higher pH, more of the neutral species would be
present, but significantly less available acid would inhibit the dehydration step. At pH
~3, we believe both of these mechanisms are working most efficiently. The
concentration of the neutral species is at the maximum, and there is sufficient acid so as
not to retard the dehydration step. A reaction profile for this type of reaction would look
similar to Figure 5.1.0d.

Figure 5.1.0d – Theoretical reaction profile with constant Ea
Illustration showing possible reaction profile of a pH dependent two step mechanism with
a static Ea regardless of pH.

Although this is a plausible argument and is consistent with Jencks theory, it is not well
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supported by our Arrhenius data. We see that the rate is changing due to a change in
activation parameters. That is, we see a situation where k1 and k2 may not be constant.
So, the Jencks argument alone is not sufficient to explain what we see from the data. One
major difference between the Jencks theory and our experiment is Jencks’ theory is
strictly a population based issue. His theory is based on a constant activation energy, and
the rate dependence is from a change in population. Our data suggests the activation
energy is changing as a function of pH. A possibly better explanation of what we see is
shown in Figure 5.1.0e. In this cartoon of a reaction profile, we can see how the
activation energies change as pH changes.

Figure 5.1.0e – Reaction profile with changing activation energy
Illustration of possible reaction profile of a pH dependent two step mechanism with Ea
changing as a function of pH.
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5.2.0 – Future Work

Further exploration is required better understand what process is occurring. One possible
experiment to further examine this theory would be to prevent the zwitterion from
forming and running the reaction at a pH higher than three. Without formation of the
zwitterion, the higher pH solutions should form mainly neutral species. The pH must still
be acidic, so as not to retard the dehydration step. This could be accomplished by
esterification of creatine. The ester group added to creatine must be small so that the ring
formation would not be sterically hindered. Dr. Price is currently repeating the
experiments for this study with the ethyl ester of creatine, and the results should help us
decipher what is happening26.

Another possible substitution would be to replace the non-reacting primary amine with
another group to prevent the protonated species from forming. A methyl group would be
small enough not to sterically hinder the cyclization from occurring and prevent the
protonated species from forming. Conducting this experiment at low pH should show a
faster cyclization rate than regular creatine due to the increased concentration of neutral
species.

Additional computer simulations for the protonated and neutral species of creatine could
also further our understanding of this reaction. These simulations could possibly find the
actual transition state of this reaction, providing a clearer mechanistic picture of the
cyclization.
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Transition State N-C = 1.561
C-O = 1.979 E = -472.6479365

APPENDIX A

SCIPCM B3LYP/6-311+G**
Isodensity Surface @ 0.0004 au

Intermediate N-C = 1.605
E = -472.7009163

139.1kJ/mol
Neutral OPEN
E = -472.721128

228.8 kJ/mol

Neutral N-H = 1.499
O-H = 1.062 C-N = 3.093
E = -472.732394
Zwitterion N-H = 1.043
O-H = 1.704 C-N = 3.199
E = -472. 7387296

29.6 kJ/mol
7.0 kJ/mol
Cyclized N-C = 1.359
E = -472.7350785

16.6 kJ/mol
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